RGEN Return on Tangible Equity | REPLIGEN CORP

REPLIGEN CORP (RGEN) Return on Tangible Equity

2026-06-30: Return Tang Equity 6.38%.
2026-03-31: Return Tang Equity 8.14%.
2025-12-31: Return Tang Equity 8.06%.
2025-09-30: Return Tang Equity 0.30%.

Complete source-backed return tang equity history.

Available history: 2010-03-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	6.38%
2026-03-31	8.14%
2025-12-31	8.06%
2025-09-30	0.30%
2025-06-30	-2.55%
2025-03-31	-4.65%
2024-12-31	-4.69%
2024-09-30	-1.25%
2024-06-30	1.53%
2024-03-31	4.02%
2023-12-31	8.64%
2023-09-30	15.04%
2023-06-30	18.77%
2023-03-31	22.73%
2022-12-31	26.48%
2022-09-30	26.62%
2022-06-30	25.33%
2022-03-31	25.24%
2021-12-31	23.19%
2021-09-30	21.92%
2021-06-30	14.08%
2021-03-31	12.10%
2020-12-31	9.60%
2020-09-30	10.24%
2020-06-30	7.24%
2020-03-31	5.89%
2019-12-31	5.64%
2019-09-30	6.50%
2019-06-30	14.01%
2019-03-31	12.73%
2018-12-31	10.78%
2018-09-30	17.10%
2018-06-30	18.06%
2018-03-31	22.96%
2017-12-31	23.60%
2017-09-30	8.47%
2017-06-30	13.61%
2017-03-31	11.22%
2016-12-31	10.70%
2016-09-30	5.11%
2016-06-30	6.25%
2016-03-31	7.02%
2015-12-31	8.62%
2015-09-30	8.11%
2015-06-30	7.33%
2015-03-31	6.99%
2014-12-31	8.37%
2014-09-30	11.84%
2014-06-30	16.09%
2014-03-31	16.72%
2013-12-31	19.36%
2013-09-30	22.51%
2013-06-30	19.94%
2013-03-31	17.67%
2012-12-31	17.03%
2012-09-30	6.15%
2012-06-30	4.83%
2012-03-31	2.43%
2011-12-31	-2.48%
2011-09-30	-1.28%
2011-06-30	-0.72%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	8.06%
2024-12-31	-4.69%
2023-12-31	6.23%
2022-12-31	26.48%
2021-12-31	23.19%
2020-12-31	9.60%
2019-12-31	5.64%
2018-12-31	10.78%
2017-12-31	23.60%
2016-12-31	10.70%
2015-12-31	8.62%
2014-12-31	8.38%
2013-12-31	19.36%
2012-12-31	17.03%
2011-12-31	-2.48%
2011-03-31	-0.07%
2010-03-31	-6.15%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
EXELIXIS, INC. (EXEL)	United States	$14.358B	16.15
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78